Asymmetry of sympathetic activity in a rat model of Parkinson's disease induced by 6-hydroxydopamine: haemodynamic, electrocardiographic and biochemical changes

被引:9
作者
Turgut, M
Jellestad, FK
Mathisen, JR
Thorsen, T
Wester, K
Aakvag, A
机构
[1] Haukeland Hosp, Dept Neurosurg, N-5021 Bergen, Norway
[2] Univ Bergen, Inst Physiol Psychol, N-5000 Bergen, Norway
[3] Univ Bergen, Inst Clin Biol, N-5021 Bergen, Norway
关键词
Parkinson's disease; substantia nigra; behaviour; sympathetic activity; 6-hydroxydopamine; rat;
D O I
10.1007/s004330050077
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We studied the effects of experimental hemiparkinsonism upon sympathetic function in rat. The rats were divided into three groups: a group given intact control, one given lesioning with 6-hydroxydopamine (6-OHDA), and one given sham operation. One day after apomorphine testing following lesioning of the substantia nigra (SN) with 6-OHDA, heart rate (HR), mean arterial blood pressure (MAP), and electrocardiogram (EGG) were monitored. Plasma norepinephrine (NE), epinephrine (E), and dopamine (DA) levels were measured. Thereafter, immunohistochemical examination was performed to detect the extent of 6-OHDA lesions, using the avidinbiotinylated peroxidase complex (ABC) method. There was no difference in the total number of tyrosine hydroxylase (TH)-positive cells and rotation responses between the right- and left-sided 6-OHDA-treated groups. On the other hand, injury of rats with unilateral 6-OHDA resulted in haemodynamic, electrocardiographic, and biochemical changes. A significant difference was found between the right-sided 6-OHDA-treated rats and the left-sided treated ones. The MAP increased in the group given left 6-OHDA treatment and to lesser extent in the sham-operated group. In contrast, MAP did not increase in the group given right 6-OHDA treatment and was significantly lower than values in both the intact control rats and the sham-treated rats. Also, only the group given right 6-OHDA injury showed a fall in the value of HR. The plasma NE level was significantly decreased in the group given right 6-OHDA treatment compared with all other groups (P < 0.005). Our results indicate that right-sided lesioning of the nigrostriatal DA pathway in the central nervous system (CNS) has greater sympathetic consequences than left-sided ones. These results also suggest that there is a differential effect of right-sided SN lesions on sympathetic cardiac innervation. The mechanism behind the confronting impairment of autonomic nervous system (ANS) could in this experiment be attributable to an asymmetric representation of sympathetic function in the brain. However, further studies will be needed before final conclusions can be made.
引用
收藏
页码:281 / 292
页数:12
相关论文
共 50 条
  • [1] Respiratory activity in the 6-hydroxydopamine model of Parkinson's disease in the rat
    Budzinska, Krystyna
    Andrzejewski, Kryspin
    ACTA NEUROBIOLOGIAE EXPERIMENTALIS, 2014, 74 (01) : 67 - 81
  • [2] The 6-hydroxydopamine Rat Model of Parkinson's Disease
    Guimaraes, Rayanne Poletti
    Ribeiro, Danilo Leandro
    dos Santos, Keila Bariotto
    Godoy, Livea Dornela
    Correa, Mirella Rosine
    Padovan-Neto, Fernando Eduardo
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2021, (176):
  • [3] Characterisation of behavioural and neurodegenerative changes induced by intranigral 6-hydroxydopamine lesions in a mouse model of Parkinson's disease
    Grealish, Shane
    Mattsson, Bengt
    Draxler, Peter
    Bjorklund, Anders
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2010, 31 (12) : 2266 - 2278
  • [4] The 6-hydroxydopamine model of Parkinson's disease
    Simola, Nicola
    Morelli, Micaela
    Carta, Anna R.
    NEUROTOXICITY RESEARCH, 2007, 11 (3-4) : 151 - 167
  • [5] The 6-Hydroxydopamine model of parkinson’s disease
    Nicola Simola
    Micaela Morelli
    Anna R. Carta
    Neurotoxicity Research, 2007, 11 : 151 - 167
  • [6] Transcriptome sequencing in a 6-hydroxydopamine rat model of Parkinson's disease
    Li, Jia
    Sun, Yajuan
    Chen, Jiajun
    GENES & GENETIC SYSTEMS, 2019, 94 (02) : 61 - 69
  • [7] Effect of varenicline on behavioral deficits in a rat model of Parkinson's disease induced by unilateral 6-hydroxydopamine lesion of substantia nigra
    Tan, Rueyal
    Bolukbasi Hatip, Funda
    Acikalin, Oznur
    Yamauchi, Atsushi
    Kataoka, Yasufumi
    Hatip-Al-Khatib, Izzettin
    BEHAVIOURAL PHARMACOLOGY, 2018, 29 (04): : 327 - 335
  • [8] Metabolic–dopaminergic mapping of the 6-hydroxydopamine rat model for Parkinson’s disease
    Cindy Casteels
    Erwin Lauwers
    Guy Bormans
    Veerle Baekelandt
    Koen Van Laere
    European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35 : 124 - 134
  • [9] Synchrotron FTIR Microspectroscopy Study of the Striatum in 6-Hydroxydopamine Rat Model of Parkinson's Disease
    Zhu Hongyan
    Xiao, Pei
    Wu Lingyan
    Bo, Liu
    Qi Zeming
    Wang Yuyin
    SPECTROSCOPY-AN INTERNATIONAL JOURNAL, 2012, 27 (04): : 229 - 238
  • [10] Morphologic changes within the cerebellar cortex in the unilateral 6-hydroxydopamine lesioned rat model for Parkinson disease
    Wu, Chenghua
    Fan, Guoguang
    Wu, Chunli
    Yu, Guibo
    Li, Zixuan
    HISTOLOGY AND HISTOPATHOLOGY, 2016, 31 (12) : 1337 - 1346